Acute effects of inhaled nitric oxide in children;Respuesta aguda a la administracion de oxido nitrico en ninos

Anales Espanoles de Pediatria

Volumn 46, Issue 6, 1997, Pages 581-586

  Lopez Herce Cid J ^a,b   Cueto Calvo, E ^a   Carrillo Alvarez, A ^a   Vazquez Garcia P ^a   Bustinza Arriortua A ^a   Moral Torrero, R ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b NONE   (Spain)

Author keywords

Acute respiratory distress syndrome; Critical care; Nitric oxide; Pulmonary hypertension

Indexed keywords

NITRIC OXIDE;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HEMODYNAMIC PARAMETERS; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; INTENSIVE CARE UNIT; MALE; NEWBORN; OXYGENATION; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY TRACT DISEASE; TREATMENT OUTCOME; NEONATAL RESPIRATORY DISTRESS SYNDROME; POSTOPERATIVE CARE;

ADMINISTRATION, INHALATION; ADOLESCENT; CHILD; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; MALE; NITRIC OXIDE; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 0031155743     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-526.
2. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329:2002-2012.
3. Lowestein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med 1994; 120:227-237.
4. López-Herce J, Carrillo A, Alcaraz A. Oxido nítrico: Alteraciones en patología humana y utilidad terapéutica en el tratamiento de la enfermedad pulmonar en la infancia. An Esp Pediatr 1994; 41:293-308.
5. Barnes PJ, Belsivi MG. Nitric oxide and lung disease. Thorax 1993; 48:1034-1043.
6. Rimar S, Gillis CN. Selective pulmonary vasodilatation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 1993; 88:2884-2887.
7. Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr 1993; 123:103-108.
8. Miller OI, Celennajer DS, Deanfiel JE, Macrae DJ. Very-low-dose inhaled nitric oxide: A selective pulmonary vasodilatador after operations for congenital heart disease. J Thorac Cardiovasc Surg 1994; 108:487-494.
9. Alcaraz A, López-Herce J, De Lucas N, Carrillo A, Sancho L, Seriñá C. Utilización del óxido nítrico inhalado en la infancia: experiencia inicial. Acta Ped Esp 1995; 53:632-638.
10. Leveque C, Hamza J, Berg A, Barbotin-Larrieu F, Laquenie G, Goutail-Flaud F, Coutourier C, Egu J-F, Mekouar R, Saint-Maurice C. Successful repair of a severe left congenital diaphragmatic hernia during continuous inhalation of nitric oxide. Anesthesiology 1994; 80:1171-1175.
11. Sitbon O, Brenot F, Denjean A, Bergeron A, Parent F, Azarian R, Hervé P, Raffestin B, Simonneau G. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. Am J Respir Crit Care Med 1995; 151:384-389.
12. Müller W, Kachel W, Lasch P, Varnholt V, König SA. Inhaled nitric oxide for avoidance of extracorporeal membrane oxygenation in the treatment of severe persistent pulmonary hypertension of the newborn. Intensive Care Med 1996; 22:71-76.
13. Rossaint R, Falke KJ, López F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328:399-405.
14. Gerlach H, Pappert O, Lewandoski K, Rossaint R, Falke KJ. Long-term inhalation with evaluated low doses of nitric oxide for selective improvements of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med 1993; 19:443-449.
15. Gerlach H, Rossaint R, Pappert A, Falke KJ. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993; 23:499-502.
16. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R, The Consensus Committee. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Intensive Cared Med 1994; 20:225-232.
17. Paulson Th E, Spear RM, Peterson BM. New concepts in the treatment of children with acute respiratory distress syndrome. J Pediatr 1995; 127:163-175.
18. Zapol WM. Minidose inhaled nitric oxide: less is better. Intensive Care Med 1993; 19:433-434.
19. Puybasset L, Stewart Th, Rouby J-J, Cluzel Ph D, Mourgeon E, Belin M-F, Arthaud M, Landaut C, Viars P. Inhaled nitric oxide reverses the increase in pulmonary vascular resistance induced by permissive hyper-capnia in patients with acute respiratory distress syndrome. Anesthesiology 1994; 80:1254-1267.
20. Cioffi WG, Ogura H. Inhaled nitric oxide in acute lung disease. New Horizons 1995; 3:73-85.
21. Wysocki M, Delclaux C, Roupie E, Langeren O, Liu N, Herman B, Lemaire F, Brochard L. Additive effect on gas exchange of inhaled nitric oxide and intravenous almirine bismesylate in the adult respiratory distress syndrome. Intensive Care Med 1994; 20:254-259.
22. Puybasset L, Rouby J-J, Mourgeon E, Cluzel P, Souhil Z, Law-Koune J-D, Stewart TH, Devilliers C, Lu Q, Roche S, Kalfon P, Vicaut E, Viars P. Factors influencing cardiopulmonary effects of inhaled nitric oxide in acute respiratory failure. Am J Respir Crit Care Med 1995; 152:318-328.
23. Abman SH, Griebel JL, Parker DK, Schmidt JM, Swanton D, Kinsella JP. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J Pediatr 1994; 124:881-888.
24. Finer NN, Etches PC, Kamstra B, Tierney AJ, Peliowsky A, Ryan CA. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr 1994; 124:302-308.
25. Day RW, Guarín M, Lynch JM, Vernon DD, Dean JM. Inhaled nitric oxide in children with severe lung disease: Results of acute and prolonged therapy with two concentrations. Crit Care Med 1996; 24:215-221.
26. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720-723.
27. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338:1173-1174.
28. Kinsella JP, Neish SR, Shaffer E, Abman AH. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340:819-820.
29. Kinsella JP, Abman SH. Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr 1995; 126:853-864.
30. Turbow R, Waffarn F, Yang L, Sills J, Hallman M. Variable oxygenation response to inhaled nitric oxide in severe persistent hypertension of the newborn. Acta Paediatr 1995; 84:1305-1308.